RABL6A promotes AKT-mTOR signaling via inactivation of the PP2A tumor suppressor [12], and numerous studies have shown that activated AKT-mTOR signaling promotes tumor angiogenesis [48]. The gene discussed is MTOR; the disease is neoplasm.